Europe Pneumonia Vaccines Market By Vaccine Type (Pneumococcal conjugate vaccine (PCV) and Pneumococcal polysaccharide vaccine (PPSV/PPV)), By Product Type (Prevnar 13, Synflorix and Pneumovax23), By sector (Public sector and Private sector), By Distribution Channel (Distribution partner companies, Non-governmental Organizations (NGO) and Government Authorities)

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Pneumonia Vaccines Market, by Vaccine Type
1.4.2 Europe Pneumonia Vaccines Market, by Product Type
1.4.3 Europe Pneumonia Vaccines Market, by Sector
1.4.4 Europe Pneumonia Vaccines Market, by Distribution Channel
1.4.5 Europe Pneumonia Vaccines Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe Pneumonia Vaccines Market by Vaccine Type
3.1 Europe Pneumococcal Conjugate Vaccine (PCV) Market by Region
3.2 Europe Pneumococcal Polysaccharide Vaccine (PPSV/PPV) Market by Region
Chapter 4. Europe Pneumonia Vaccines Market by Product Type
4.1 Europe Prevnar 13 Market by Region
4.2 Europe Synflorix Market by Region
4.3 Europe Pneumovax 23 Market by Region
Chapter 5. Europe Pneumonia Vaccines Market by Sector
5.1 Europe Private sector Market by Region
5.2 Europe Public sector Market by Region
5.2.1 Europe Pneumonia Vaccines Market by Distribution Channel
5.3 Europe Distribution Partner Companies Market by Region
5.4 Europe Non-Governmental Organizations (NGO) Market by Region
5.5 Europe Government Authorities Market by Region
Chapter 6. Europe Pneumonia Vaccines Market by Country
6.1 Germany Pneumonia Vaccines Market
6.1.1 Germany Pneumonia Vaccines Market by Vaccine Type
6.1.2 Germany Pneumonia Vaccines Market by Product Type
6.1.3 Germany Pneumonia Vaccines Market by Sector
6.1.4 Germany Pneumonia Vaccines Market by Distribution Channel
6.2 UK Pneumonia Vaccines Market
6.2.1 UK Pneumonia Vaccines Market by Vaccine Type
6.2.2 UK Pneumonia Vaccines Market by Product Type
6.2.3 UK Pneumonia Vaccines Market by Sector
6.2.4 UK Pneumonia Vaccines Market by Distribution Channel
6.3 France Pneumonia Vaccines Market
6.3.1 France Pneumonia Vaccines Market by Vaccine Type
6.3.2 France Pneumonia Vaccines Market by Product Type
6.3.3 France Pneumonia Vaccines Market by Sector
6.3.4 France Pneumonia Vaccines Market by Distribution Channel
6.4 Russia Pneumonia Vaccines Market
6.4.1 Russia Pneumonia Vaccines Market by Vaccine Type
6.4.2 Russia Pneumonia Vaccines Market by Product Type
6.4.3 Russia Pneumonia Vaccines Market by Sector
6.4.4 Russia Pneumonia Vaccines Market by Distribution Channel
6.5 Spain Pneumonia Vaccines Market
6.5.1 Spain Pneumonia Vaccines Market by Vaccine Type
6.5.2 Spain Pneumonia Vaccines Market by Product Type
6.5.3 Spain Pneumonia Vaccines Market by Sector
6.5.4 Spain Pneumonia Vaccines Market by Distribution Channel
6.6 Italy Pneumonia Vaccines Market
6.6.1.1.1 Italy Pneumonia Vaccines Market by Vaccine Type
6.6.2 Italy Pneumonia Vaccines Market by Product Type
6.6.3 Italy Pneumonia Vaccines Market by Sector
6.6.4 Italy Pneumonia Vaccines Market by Distribution Channel
6.7 Rest of Europe Pneumonia Vaccines Market
6.7.1 Rest of Europe Pneumonia Vaccines Market by Vaccine Type
6.7.2 Rest of Europe Pneumonia Vaccines Market by Product Type
6.7.3 Rest of Europe Pneumonia Vaccines Market by Sector
6.7.4 Rest of Europe Pneumonia Vaccines Market by Distribution Channel
Chapter 7. Company Profiles
7.1 GLAXOSMITHKLINE PLC (GSK)
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.1 Recent strategies and developments:
7.1.1.1 Collaboration, partnerships and agreements:
7.1.1.2 Expansion:
7.1.2 SWOT Analysis
7.2 LG Corporation (LG Chemicals Ltd.)
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 SWOT Analysis
7.3 Panacea Biotec Limited
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Collaboration, partnerships and agreements:
7.3.6 SWOT Analysis
7.4 Pfizer, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Collaboration, partnerships and agreements:
7.4.5.2 Product launch:
7.4.6 SWOT Analysis
7.5 PnuVax Incorporated
7.5.1 Company Overview
7.6 Poonawalla Investments & Industries Pvt. Ltd. (Serum Institute of India Pvt. Ltd.)
7.6.1 Company Overview
7.7 Shenzhen Kangtai Biological Products Co., Ltd. (Beijing Minhai Biotechnology Corporation Limited)
7.7.1 Company Overview
7.8 SK Holdings Co., Ltd. (SK Bioscience, Inc.)
7.8.1 Company overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expenses
7.9 Walvax Biotechnology Co., Ltd.
7.9.1 Company Overview
7.9.2 Recent strategies and developments:
7.9.2.1 Product launch:
7.1 Merck & Co., Inc.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expenses
7.10.5 Recent strategies and developments:
7.10.5.1 Collaboration, partnerships and agreements:
7.10.5.2 Product launch:
7.10.6 SWOT Analysis